InvestorsHub Logo
Followers 0
Posts 324
Boards Moderated 0
Alias Born 03/23/2017

Re: None

Friday, 10/20/2017 2:48:17 PM

Friday, October 20, 2017 2:48:17 PM

Post# of 44784
Cleveland Biolabs (CBLI) has 150 humans safely tested with Entolimod for ARS. Have already submitted a pre-Emergency Use Authorization dossier to the FDA for review. They have also been granted both Fast Track and Orphan Drug Status for reducing the risk of death following a potentially lethal dose of radiation. Looking at their ARS cure, they have a huge advantage of only needing to be administered once. A disadvantage of their treatment would be that (thus far) I have not seen any ARS data if injected at the +48 hour mark, only at +24. I don’t know why, but they have had a prolonged hold up with their product. I’m not sure why, but Entolimod has been around for a long time and has been proven effective against ARS in animals and has been tested for safety in 150 human subjects. Also being researched for cancer treatment. We are not the only game in town and we need to pick up the pace IMO.